Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review

被引:0
|
作者
Ioannis Asproudis
Andreas Katsanos
Nikolaos Kozeis
Alexandra Tantou
Anastasios G. Konstas
机构
[1] University of Ioannina,Department of Ophthalmology
[2] Ophthalmica Institute,1st and 3rd University Departments of Ophthalmology
[3] Aristotle University of Thessaloniki,undefined
来源
Advances in Therapy | 2017年 / 34卷
关键词
Anti-TNF; Biological agents; DMARDS; Juvenile idiopathic arthritis; JIA; Methotrexate; Topical steroids; Uveitis;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic uveitis is a common extra-articular manifestation of juvenile idiopathic arthritis. The classic clinical picture is one of chronic anterior uveitis, which usually remains asymptomatic until ocular complications arise. The risk of uveitis is increased in girls with an early onset of oligoarthritis and positive antinuclear antibodies. Even though the inflammation in patients with juvenile idiopathic arthritis is initially limited in the anterior part of the eye, chronic active inflammation may eventually cause significant damage to the posterior pole. Complications may include band keratopathy, cataract, secondary glaucoma, posterior synechiae, cystoid macular edema, and hypotony. The cooperation of ophthalmologists with rheumatologists may help define the best treatment plan. The ophthalmic therapeutic regimen includes topical corticosteroids and mydriatics, while in severe cases immunosuppressive and biological agents are introduced. Surgical management of complications might be needed.
引用
收藏
页码:2558 / 2565
页数:7
相关论文
共 50 条
  • [21] Juvenile idiopathic arthritis and its associated uveitis
    Maleki, Arash
    Patel, Priya D. D.
    Foster, C. Steven
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1157 - 1169
  • [22] Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
    R Joos
    C Wouters
    J Dehoorne
    D Elewaut
    Pediatric Rheumatology, 9 (Suppl 1)
  • [23] Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis
    Kolomeyer, Anton M.
    Tu, Yufei
    Miserocchi, Elisabetta
    Ranjan, Mangala
    Davidow, Amy
    Chu, David S.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (04) : 377 - 385
  • [24] Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
    Iannone, Claudia
    Marelli, Luca
    Costi, Stefania
    Pellico, Maria Rosa
    La Franca, Lamberto
    Caporali, Roberto
    Miserocchi, Elisabetta
    CHILDREN-BASEL, 2023, 10 (03):
  • [25] Treatment with TNF inhibitors for uveitis associated with juvenile idiopathic arthritis
    Levy-Clarke, Grace
    Gangaputra, Sapna
    Nussenblatt, Robert
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (11): : 608 - 609
  • [26] TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
    Violetta Opoka-Winiarska
    Jacek Postępski
    Agnieszka Korobowicz-Markiewicz
    Anna Bodajko-Grochowska
    Aleksandra Szabat
    Andrzej Emeryk
    Pediatric Rheumatology, 12 (Suppl 1)
  • [27] Juvenile Idiopathic Arthritis Associated Uveitis
    Carlsson, Emil
    Beresford, Michael W.
    Ramanan, Athimalaipet, V
    Dick, Andrew D.
    Hedrich, Christian M.
    CHILDREN-BASEL, 2021, 8 (08):
  • [28] Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
    Tappeiner, Christoph
    Miserocchi, Elisabetta
    Bodaghi, Bahram
    Kotaniemi, Kaisu
    Mackensen, Friederike
    Gerloni, Valeria
    Quartier, Pierre
    Lutz, Thomas
    Heiligenhaus, Arnd
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) : 706 - 711
  • [29] Therapeutic advances in juvenile idiopathic arthritis - associated uveitis
    Gueudry, Julie
    Touhami, Sara
    Quartier, Pierre
    Bodaghi, Bahram
    CURRENT OPINION IN OPHTHALMOLOGY, 2019, 30 (03) : 179 - 186
  • [30] Biologics for treatment of juvenile idiopathic arthritis - Update 2007
    Horneff, G.
    AKTUELLE RHEUMATOLOGIE, 2007, 32 (03) : 128 - 135